Infrared optical imaging of matrix metalloproteinases (MMPs) up regulation following ischemia reperfusion is ameliorated by hypothermia

BMC Neuroscience

Volumn 13, Issue 1, 2012, Pages

  Barber, Philip A ^a,c   Rushforth, David ^b   Agrawal, Smriti ^a   Tuor, Ursula I ^a,b,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B;

ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; BRAIN SURGERY; CONTROLLED STUDY; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPY; HYPOTHERMIA; IMAGE PROCESSING; IN VIVO STUDY; INFRARED RADIATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; REPERFUSION INJURY;

ANALYSIS OF VARIANCE; ANIMALS; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FUNCTIONAL LATERALITY; HYPERTHERMIA, INDUCED; INFARCTION, MIDDLE CEREBRAL ARTERY; INFRARED RAYS; LASER-DOPPLER FLOWMETRY; MALE; METALLOPROTEASES; MICE; MICE, INBRED C57BL; MOLECULAR PROBES; REPERFUSION; TIME FACTORS; UP-REGULATION;

EID: 84862753314     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-13-76     Document Type: Article

References (27)

1. Del Zoppo GJ. The neurovascular unit, matrix proteases, and innate inflammation. Ann N Y Acad Sci 2010, 1207:46-49. 10.1111/j.1749-6632.2010.05760.x, 20955425.
2. Yong VW, Krekoski CA, Forsyth PA, Bell R, Edwards DR. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci 1998, 21:75-80. 10.1016/S0166-2236(97)01169-7, 9498303.
3. Rosenberg GA, Navratil M, Barone F, Feuerstein G. Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J Cereb Blood Flow Metab 1996, 16:360-366.
4. Sumii T, Lo EH. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke 2002, 33:831-836. 10.1161/hs0302.104542, 11872911.
5. Ramos-Fernandez M, Bellolio MF, Stead LG. Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review. J Stroke Cerebrovasc Dis 2011, 20:47-54. 10.1016/j.jstrokecerebrovasdis.2009.10.008, 21044610.
6. MacLellan CL, Clark DL, Silasi G, Colbourne F. Use of prolonged hypothermia to treat ischemic and hemorrhagic stroke. J Neurotrauma 2009, 26:313-323. 10.1089/neu.2008.0580, 19216634.
7. Choi HA, Badjatia N, Mayer SA. Hypothermia for acute brain injury-mechanisms and practical aspects. Nat Rev Neurol 2012, 8(4):214-22.
8. Pires PW, Rogers CT, McClain JL, Garver HS, Fink GD, Dorrance AM. Doxycycline, a matrix metalloprotease inhibitor, reduces vascular remodeling and damage after cerebral ischemia in stroke-prone spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2011, 301(1):H87-97. 10.1152/ajpheart.01206.2010, 3129920, 21551278.
9. Rodriguez-Gonzalez R, Sobrino T, Rodriguez-Yanez M, Millan M, Brea D, Miranda E, et al. Association between neuroserpin and molecular markers of brain damage in patients with acute ischemic stroke. J Transl Med 2011, 9:58. 10.1186/1479-5876-9-58, 3113955, 21569344.
10. Chaudhry K, Rogers R, Guo M, Lai Q, Goel G, Liebelt B, et al. Matrix metalloproteinase-9 (MMP-9) expression and extracellular signal-regulated kinase 1 and 2 (ERK1/2) activation in exercise-reduced neuronal apoptosis after stroke. Neurosci Lett 2010, 474:109-114. 10.1016/j.neulet.2010.03.020, 20298757.
11. Yoon SM, Myung SJ, Ye BD, Kim IW, Lee NG, Ryu YM, et al. Near-infrared fluorescence imaging using a protease-specific probe for the detection of colon tumors. Gut Liver 2010, 4:488-497. 10.5009/gnl.2010.4.4.488, 3021604, 21253297.
12. Klohs J, Baeva N, Steinbrink J, Bourayou R, Boettcher C, Royl G, et al. In vivo near-infrared fluorescence imaging of matrix metalloproteinase activity after cerebral ischemia. J Cereb Blood Flow Metab 2009, 29:1284-1292. 10.1038/jcbfm.2009.51, 19417756.
13. Truettner JS, Alonso OF, Dalton DW. Influence of therapeutic hypothermia on matrix metalloproteinase activity after traumatic brain injury in rats. J Cereb Blood Flow Metab 2005, 25:1505-1516. 10.1038/sj.jcbfm.9600150, 15959464.
14. Baumann E, Preston E, Slinn J, Stanimirovic D. Post-ischemic hypothermia attenuates loss of the vascular basement membrane proteins, agrin and SPARC, and the blood-brain barrier disruption after global cerebral ischemia. Brain Res 2009, 1269:185-197.
15. Horstmann S, Koziol JA, Martinez-Torres F, Nagel S, Gardner H, Wagner S. Sonographic monitoring of mass effect in stroke patients treated with hypothermia. Correlation with intracranial pressure and matrix metalloproteinase 2 and 9 expression. J Neurol Sci 2009, 276:75-78. 10.1016/j.jns.2008.08.038, 18834996.
16. Nagel S, Su Y, Horstmann S, Heiland S, Gardner H, Koziol J, et al. Minocycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat: effects on BBB breakdown and MMP expression in the acute and subacute phase. Brain Res 2008, 1188:198-206.
17. Barber PA, Hoyte L, Colbourne F, Buchan A. Temperature regulated model of focal ischemia in the mouse: a study with histopathological and behavioural outcomes. Stroke 2004, 35:1720-1725. 10.1161/01.STR.0000129653.22241.d7, 15155973.
18. Kasischke KA, Lambert EM, Panepento B, Sun A, Gelbard HA, Burgess RW, et al. Two-photon NADH imaging exposes boundaries of oxygen diffusion in cortical vascular supply regions. J Cereb Blood Flow Metab 2011, 31:68-81. 10.1038/jcbfm.2010.158, 3049466, 20859293.
19. Mayevsky A, Rogatsky GG. Mitochondrial function in vivo evaluated by NADH fluorescence: from animal models to human studies. Am J Physiol Cell Physiol 2007, 292:C615-C640.
20. Chang DI, Hosomi N, Lucero J, Heo JH, Abumiya T, Mazar AP, et al. Activation systems for latent matrix metalloproteinase-2 are upregulated immediately after focal cerebral ischemia. J Cereb Blood Flow Metab 2003, 23:1408-1419.
21. Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 2007, 27:697-709.
22. Dong X, Song YN, Liu WG, Guo XL. Mmp-9, a potential target for cerebral ischemic treatment. Curr Neuropharmacol 2009, 7:269-275. 10.2174/157015909790031157, 2811860, 20514206.
23. Ponnampalam SN, Mayberg MR. Mediators of blood-brain barrier disruption and potential therapeutic interventions for protection of the barrier following focal ischemia. Clin Neurosurg 2004, 51:112-119.
24. Horstmann S, Kalb P, Koziol J, Gardner H, Wagner S. Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies. Stroke 2003, 34:2165-2170. 10.1161/01.STR.0000088062.86084.F2, 12907822.
25. Burk J, Burggraf D, Vosko M, Dichgans M, Hamann GF. Protection of cerebral microvasculature after moderate hypothermia following experimental focal cerebral ischemia in mice. Brain Res 2008, 1226:248-255.
26. Lee JE, Yoon YJ, Moseley ME, Yenari MA. Reduction in levels of matrix metalloproteinases and increased expression of tissue inhibitor of metalloproteinase-2 in response to mild hypothermia therapy in experimental stroke. J Neurosurg 2005, 103:289-297. 10.3171/jns.2005.103.2.0289, 16238087.
27. Lo EH. A new penumbra: transitioning from injury into repair after stroke. Nat Med 2008, 14:497-500. 10.1038/nm1735, 18463660.